Sponsored Content

A New Alliance: ICROM and PolyCrystalLine

ICROM and PolyCrystalLine SpA announce their strategic and exclusive partnership to provide integrated solutions for chemical development and custom manufacturing of APIs.

Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment

Today, biopharma companies face growing challenges when capacity is at a premium. Investment decisions must be made to ultimately determine the expansion of facilities, headcounts and technology choices necessary to maintain supply. Discover the...

Getting Your Biologic to Clinic Faster & More Efficiently

Executive Summary There are a range of benefits in using an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages. Partnering with one supplier that understands how to best...

Supply Chain Security -- If Your API Supply Is Important, You Should Take Five Minutes To Read This

We all know that active pharmaceutical ingredient (API) end user supply chain security is a critical component to getting the finished dosage to market. Securing the supply chain means that discipline, diligence, expertise and compliance are...

Embarking Upon the Commercial Manufacturing Journey for a Biologic: Strategies to Achieve Successful Approval & Launch

In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey.

Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment

The Role of cGMP Chemicals in Cell & Gene Therapies

Improvements in raw material inputs are necessary in order to deploy cell & gene therapies economically and at scale. Watch an on-demand webinar featuring Avantor experts to learn about challenges associated with using non-GMP raw materials, as...

Advancing Gene Therapy by Solving Challenges in Scale-Up & Manufacturing

Today’s biologic drugs give the promise of breakthrough treatment options for the world’s most challenging diseases and chronic conditions. In the case of gene therapies, the impact of these treatments will only expand as they are administered to...

New Choices to Help Improve mAbs Downstream Manufacturing Efficiency: Introducing the J.T.Baker® BAKERBOND® PROchievA™ Recombinant Protein A Resin

An integrated mAbs downstream purification process featuring Avantor J.T.Baker® BAKERBOND® PROchievA™ recombinant protein A chromatography columns and resins can enable significant throughput improvement while removing of critical impurities.

Small-Molecule Matters: Integration in Drug Development

How a collaborative approach between small and large drug developers with the right CDMO can overcome critical challenges to achieve greater efficiencies in quality, time, and cost – at every stage of the small molecule drug lifecycle.

COVID-19 and What’s Next for API Sourcing?

The pandemic challenged the global supply chain instantly. Geopolitical tensions and the call for localizations and self-reliance are further adding to the complexity of today’s API souring. In this article we look on supply chain security in a...

A Cambrex Webinar - Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh, discusses the importance of understanding crystallization processes to avoid unnecessary cost, risk and development delays.

Page 1 of 2

Sponsored Content

A New Alliance: ICROM and PolyCrystalLine

Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment

Getting Your Biologic to Clinic Faster & More Efficiently

Supply Chain Security -- If Your API Supply Is Important, You Should Take Five Minutes To Read This

Embarking Upon the Commercial Manufacturing Journey for a Biologic: Strategies to Achieve Successful Approval & Launch

Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment

The Role of cGMP Chemicals in Cell & Gene Therapies

Advancing Gene Therapy by Solving Challenges in Scale-Up & Manufacturing

New Choices to Help Improve mAbs Downstream Manufacturing Efficiency: Introducing the J.T.Baker® BAKERBOND® PROchievA™ Recombinant Protein A Resin

Small-Molecule Matters: Integration in Drug Development

COVID-19 and What’s Next for API Sourcing?

A Cambrex Webinar - Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Overcoming Challenges to Deliver Fixed Dose Combination (FDC) Drug Products

Q&A with Stephan Haitz, President, CDMO Sales & Marketing at Cambrex

A Cambrex Webinar- De-Risking the Solid Form Landscape of an API

Future focus: Our 2020 vision

Sponsored Content

Login Form